Explore the delicate intersection of patient well-being and surgical intervention as we delve into the reasons and outcomes for removing ruptured breast implants absent of cancer concerns.
– by James
Note that James is a diligent GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Ruptured breast implant removal because of patient anxiety in the absence of breast implant-associated anaplastic large cell lymphoma.
Takahashi et al., Nagoya J Med Sci 2023
DOI: 10.18999/nagjms.85.4.852
Case Report: Concurrent BIA-ALCL and Breast Cancer Not Detected Preoperatively
A 52-year-old woman with a history of bilateral silicone breast implants presented with right axillary lymphadenopathy and intracapsular ruptures, 15 years post-augmentation. Despite negative preoperative tests for breast cancer and BIA-ALCL, including flow cytometry on the exudate, the decision was made to remove the ruptured implants due to worsening rupture and patient anxiety regarding BIA-ALCL. Post-removal, the patient experienced an uneventful recovery and reduced anxiety, despite breast deformity.
Significance: This case highlights the importance of considering patient concerns and potential implant complications, even with negative test results for BIA-ALCL and breast cancer. It underscores the need for careful monitoring and the option of explantation to alleviate anxiety related to implant-associated risks.
Contribution to Literature: The report contributes to the discussion on managing patients with breast implants who exhibit symptoms suggestive of BIA-ALCL or breast cancer, emphasizing patient-centered care and the psychological impact of implant-associated health concerns.